SG
MNOV icon

StoneX Group’s MediciNova MNOV Stock Holding History

StoneX Group’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,200
Closed -$25.2K – 1120
2025
Q4 		$25.2K Buy
+19,200
New +$26.5K ﹤0.01% 962

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

StoneX Group's MNOV Position: Q1 2026 in Review

StoneX Group sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 19,200 shares — an estimated $25.2K sold.

StoneX Group first reported a position in MNOV in Q4 2025 and held it in 1 quarter. The position peaked at $25.2K in Q4 2025. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • StoneX Group reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 19,200 MediciNova shares in Q1 2026, an estimated $25.2K.
  • StoneX Group first reported a position in MediciNova in Q4 2025 and held it in 1 quarter.
  • StoneX Group's MediciNova position peaked at $25.2K in Q4 2025.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.